Literature DB >> 20534097

Response to oral cyclosporine therapy and high sensitivity-CRP level in chronic idiopathic urticaria.

Tsutomu Ohtsuka1.   

Abstract

BACKGROUND: Chronic idiopathic urticaria (CIU) is often resistant to common treatment of uriticaria.
OBJECTIVE: To find out clinical and laboratory findings affecting the response of oral cyclosporine therapy in CIU. SUBJECTS AND METHODS: The response of oral cyclosporine therapy in 15 patients with CIU (male:female = 5:10, age 16-60 years old, mean 40.0 years old) was studied. Cyclosporine trough level was measured with an enzyme-multiplied immunoassay, and high sensitivity-CRP was measured with a nephelometric assay. The relation between high sensitivity-CRP level and clinical and laboratory findings in CIU was also studied.
RESULTS: All the 15 CIU patients responded to oral cyclosporine therapy. High sensitivity-CRP levels before the start of therapy were elevated in nine of 15 CIU patients. The distributions of treatment duration and basophile leukocytes counts in elevated high sensitivity-CRP patients (8.7 +/- 1.3 months, 0.20 +/- 0.05%) were significantly shorter and elevated than those in patients showing no elevation (22.7 +/- 1.7 months, 0.40 +/- 0.05%) (P < 0.05, P < 0.05), respectively. No other clinical and laboratory findings between patients with elevated and not elevated high sensitivity-CRP showed any significant differences.
CONCLUSION: Chronic idiopathic urticaria patients with elevated high sensitivity-CRP showed good response to oral cyclosporine therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20534097     DOI: 10.1111/j.1365-4632.2010.04384.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  5 in total

Review 1.  Chronic spontaneous urticaria: latest developments in aetiology, diagnosis and therapy.

Authors:  Christian Vestergaard; Mette Deleuran
Journal:  Ther Adv Chronic Dis       Date:  2015-11       Impact factor: 5.091

Review 2.  Chronic Urticaria: An Overview of Treatment and Recent Patents.

Authors:  Kam L Hon; Alexander K C Leung; Wing G G Ng; Steven K Loo
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2019

3.  Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications.

Authors:  Ilaria Puxeddu; Fiorella Petrelli; Francesca Angelotti; Cristina Croia; Paola Migliorini
Journal:  J Asthma Allergy       Date:  2019-09-20

4.  Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: can we define better-responding endotypes?

Authors:  Emek Kocatürk; Emel Bülbül Başkan; Özlem Su Küçük; Mustafa Özdemir; Sinem Örnek; Pelin Kuteyla Can; Eda Haşal; Burhan Engin; Nilgün Atakan; Erkan Alpsoy
Journal:  An Bras Dermatol       Date:  2022-07-16       Impact factor: 2.113

Review 5.  The challenges of chronic urticaria part 2: Pharmacological treatment, chronic inducible urticaria, urticaria in special situations.

Authors:  Mario Sánchez-Borges; Ignacio J Ansotegui; Ilaria Baiardini; Jonathan Bernstein; Giorgio Walter Canonica; Motohiro Ebisawa; R Maximiliano Gomez; Sandra González-Diaz; Bryan Martin; Mário Morais de Almeida; Jose Antonio Ortega Martell
Journal:  World Allergy Organ J       Date:  2021-06-03       Impact factor: 4.084

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.